Aralez Pharma (ARLZ) Tops Q3 EPS by 5c; Boosts FY16 Revenue Outlook

November 7, 2016 7:16 AM EST
Get Alerts ARLZ Hot Sheet
Price: $5.06 -0.78%

Today's EPS Names:
GCO, ALCO, BIG, More
Trade ARLZ Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Aralez Pharma (NASDAQ: ARLZ) reported Q3 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $136 million versus the consensus estimate of $12.23 million.

GUIDANCE:

Aralez Pharma sees FY2016 revenue of $54-62 million, versus prior guidance of $48-58 million and the consensus of $47.1 million.

For earnings history and earnings-related data on Aralez Pharma (ARLZ) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Guidance

Related Entities

Earnings

Add Your Comment